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Objective: Although a heritable contribution to risk for major depressive disorder (MDD) has been established
and neural alterations in patients have been identiﬁed through neuroimaging, it is unclear which brain abnor-
malities are related to genetic risk. Studies on brain structure of high-risk subjects – such as individuals carrying
a familial liability for the development of MDD – can provide information on the potential usefulness of these
measures as intermediate phenotypes of MDD.
Methods: 63 healthy ﬁrst-degree relatives of patients with MDD and 63 healthy controls underwent structural
magnetic resonance imaging. Regional gray matter volumes were analyzed via voxel-based morphometry
(VBM).
Results:Whole-brain analysis revealed signiﬁcantly larger gray matter volume in the bilateral amygdala in ﬁrst-
degree relatives of patients with MDD. Furthermore, relatives showed signiﬁcantly larger graymatter volume in
anatomical structures found relevant toMDD in previous literature, speciﬁcally in the bilateral hippocampus and
amygdala as well as the left dorsolateral prefrontal cortex (DLPFC). Bilateral DLPFC volume correlated positively
with the experience of negative affect.
Conclusions: Larger gray matter volume in healthy relatives of MDD patients point to a possible vulnerability
mechanism in MDD etiology and therefore extend knowledge in the ﬁeld of high-risk approaches in MDD.© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
In recent years, research on neurobiological risk factors formajor de-
pressive disorder (MDD) has increasingly identiﬁed neurobiological
contributions to disease risk. This is important since MDD is one of the
leading causes of years lost due to disability (World Health
Organization, 2009) and is associated with high mortality rates
(Palazidou, 2012). One of the major methodological approaches in this
domain has been neuroimaging. Several studies in patients reported
functional as well as structural brain alterations (Drevets et al., 2008).
Functional ﬁndings suggest dysregulation in neural circuits involving
the prefrontal cortex as well as limbic structures (including theand Psychotherapy, Charité —
platz 1, Berlin 10117, Germany.
uk-Seiferth).
equally to this work.
. This is an open access article underamygdala and hippocampus) (Price and Drevets, 2012). In line with
these ﬁndings are results from structural imaging: Meta-analyses
have highlighted volume reductions in the bilateral anterior cingulate
cortex (ACC), dorsomedial frontal cortex, right middle frontal gyrus
extending into the precentral gyrus, bilateral putamen, caudate, and
right anterior insula/inferior frontal cortex in MDD (Bora et al., 2012).
Arnone et al. (2012) described volume reductions in the frontal,
orbitofrontal and cingulate cortices, hippocampus and striatum. Yet, as
has been shown in a reviewby Frodl et al. (2008), someof theseﬁndings
have been inconsistent, e.g., those concerning amygdala volumes. Di-
verging results might be due tomethodological differences of study de-
sign and data analysis. Moreover, biological variables (e.g., age and sex)
as well as psychopathological factors (e.g., age of onset, course of the
disease and medication) might contribute to inconsistent ﬁndings
(Arnone et al., 2012). Even given widespread and replicable structur-
al–functional alterations in patients compared to controls, it remains
unclear whether such changes occur after the manifestation of MDD
symptoms, whether they represent risk factors for the development of
MDD, or whether they are related to confounds such as comorbidity,the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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ing a severe mental illness.
Research on etiology of MDD has shown that multiple factors con-
tribute to themanifestation of thedisorder.MDDetiology is linked to in-
teractions between genetic vulnerability – indexed not only by familial
liability, but also by heritable traits such as neuroticism – and biograph-
ical/ environmental factors such as adverse life events (Burke et al.,
2005). Often, risk factors are combined. For instance, patients with a
family history of depression show a lower age of onset and are more
likely to have recurrent depressive phases (Hollon et al., 2006). With
an overall heritability of 30–40%, MDD is less strongly genetically deter-
mined than other severemental illnesses, which emphasizes the impor-
tance of gene–environment interactions. One strategy to disentangle
the complex network of inﬂuencing factors is to focus on high-risk sub-
jects for MDD. Healthy ﬁrst-degree relatives of MDD patients (H1stR)
enable the investigation of vulnerability factors as well as resilience
markers related to heritable or shared environmental (e.g., early famil-
ial) factors. While vulnerability factors are thought to increase risk of
mental illness, resilience factors are considered to facilitate healthy
functioning. Applied to quantitative, more biologically based measures
such as neuroimaging, these studies add to the search for intermediate
(or “endo”-) phenotypes. One necessary, but by nomeans sufﬁcient, cri-
terion for an endophenotype is that markers found in affected family
members should also be found in nonaffected family members at a
rate higher than that of the general population (Gottesman and Gould,
2003). Conversely, ﬁndings opposite in directionality between patients
and their familymembers in similar systemsmaypoint to resilience fac-
tors protecting healthy relatives from manifest illness despite their ge-
netic susceptibility. In the domain of brain structure, few manual
tracing and voxel-based morphometry (VBM) studies searching for
MDD endophenotypes have been published to date. Manual tracing
studies revealed smaller hippocampal but larger amygdala volume in
high-risk subjects (Boccardi et al., 2010; Rao et al., 2010; Saleh et al.,
2012). The reduction in hippocampal volume in high-risk subjects com-
pared to healthy controls or MDD patients was conﬁrmed by VBM
(Amico et al., 2011; Baaré et al., 2010; Carballedo et al., 2012; Chen
et al., 2010; de Geus et al., 2007). Furthermore, VBM studies exhibited
a reduction in local gray matter in the dorsolateral prefrontal cortex
(DLPFC) (Amico et al., 2011; Carballedo et al., 2012). Nevertheless, the
explanatory power of previous results regarding the potential structural
endophenotypes of MDD is limited due to heterogeneity in sample
sizes, studied risk populations and applied methods, e.g. region-of-
interest (ROI) based analyses only.
To advance the data available in this ﬁeld, we collected structural
magnetic resonance imaging (MRI) data from a large sample of H1stR
and matched healthy control subjects without any familial history of
psychiatric illness (HC) and conducted a whole-brain VBM-analysis,
thereby applying a very conservative statistical threshold. For consis-
tency with the literature, we additionally tested our data for effects in
regions previously observed using small volume alpha error adjust-
ment. This approach decreases the probability of false positive as well
as false negative ﬁndings and provides new insights in brain structural
correlates linked to the genetic risk for MDD.
2. Methods and materials
2.1. Participants
All subjects were enrolled in a multicenter study (Esslinger et al.,
2009) conducted by the Charité — Universitätsmedizin Berlin, the
Universitätsklinikum Bonn and the Zentralinstitut für Seelische Ge-
sundheit, Mannheim. The study was performed in accordance with
the latest version of the Declaration of Helsinki and approved by the
local Ethics Committees. Subjects participated in the study after provid-
ing written informed consent. 63 H1stR (38 females; 21 subjects from
Berlin, 21 from Bonn and 21 from Mannheim) were measured and63 HC (38 females; 21 subjects from Berlin, 21 from Bonn and 21 from
Mannheim) matched for age and sex were taken from a larger study
sample. Affected relatives of the H1stR group (43 offspring, 17 siblings,
1 parent, 2 NA) were examined by an experienced psychiatrist or clini-
cal psychologist using the German version of the Structured Clinical In-
terview for DSM-IV (SCID-I) (First et al., 2002) or had to provide a
medical report conﬁrming a major depressive disorder. Both the H1stR
and theHC group had no history of any neurological disorder or lifetime
psychiatric axis I disorder including drug or alcohol dependence as ver-
iﬁed by an interview according to the Screening Interview for DSM-IV
axis I disorders. Further, subjects in the HC groupwere questioned care-
fully whether there is any knowledge about psychiatric disorders in
their family, and special emphasiswas put on ﬁrst degree relatives. Sub-
jects with axis 1 disorders or unclear diagnoses in their families were
not included in the study sample. Handednesswasmeasured by the Ed-
inburgh Handedness Inventory (Oldﬁeld, 1971) (H1stR: 55 right
handers, 6 left handers, 2 both hander; HC: 57 right handers, 4 left
handers, 2 both hander). In addition, years of education and premorbid
intelligence assessed by the multiple choice verbal intelligence test
(MWT-B) (Lehrl, 2005) as well as clinical scales such as the Symptom
Check List (SCL-90-R) with the subscales Global Severity Index (SCL-
GSI) and Depression (SCL-Depr) (Derogatis, 1983) were assessed. No
signiﬁcant difference between the two groups were found (see
Table 1). Furthermore, a composite score (NegAff) comprising three
self-report measures associated with the experience of negative affect
was included, in detail: 1) the trait form of the Spielberger State/Trait
Anxiety Inventory (STAI) (Spielberger, 1989) for the assessment of feel-
ings of tension, fear and worry; 2) the neuroticism scale from the NEO
ﬁve-factor inventory (Costa and McCrae, 1992) which assesses the de-
gree to which an individual experiences negative affects such as anger,
sadness and guilt; and 3) the harm avoidance scale of the Temperament
and Character Inventory (TCI) (Cloninger, 1994)whichmeasures a per-
sonality trait characterized by anticipatory worry, pessimism, easy fa-
tigue and shyness. The composite score was calculated by using the
average of the Z-scores for each individual scale as suggested previously
(Holmes et al., 2012). The two groups did not differ on this scale either.
2.2. Statistical analysis of sociodemographical, psychometrical and clinical
data
Statistical analyses were performed using the software package
MATLAB (MATLAB 7.8, The MathWorks Inc., Natick, MA, 2009). Due to
violation of statistical assumptions for parametrical testing (normal dis-
tribution as assessed by the Kolmogorov–Smirnov test or the level of
measurement), the medians of age, years of education, IQ, SCL-GSI and
SCL-Depr and the composite score NegAff were tested regarding group
differences via non-parametrical Wilcoxon rank-sum test (see
Supplementary Table S1).
2.3. MRI acquisition
StructuralMRI datawere acquired on a 3 Tesla SiemensMAGNETOM
Tim Trio MRI system (Siemens, Erlangen, Germany) at all three study
sites. All subjects underwent a T1-weighted three-dimensional magne-
tization prepared rapid gradient echo (MP-RAGE) sequencewith an iso-
tropic spatial resolution of 1 mm3 (repetition time = 1.57 s, echo
time = 2.74 ms, ﬂip angle = 15°). Additional quality control measure-
ments via EPI sequences were conducted at all study sites on every
day of data collection according to a multicenter quality assurance pro-
tocol (Friedman and Glover, 2006), revealing stable signals over time
and comparable quality between sites.
2.4. Voxel-based morphometry (VBM)
MRI data processing was performed according to an established
voxel-basedmorphometry protocol using the VBM8 toolbox (Structural
Table 1
Sociodemographical and clinical data. Abbreviations: H1stR— healthy ﬁrst-degree relatives of MDD patients; HC— healthy control subjects; MWT-B—multiple choice verbal intelligence
test; SCL-90-R — Symptom Check List; GSI — Global Severity Index, *IQ.
Variable H1stR
(25♂/38 ♀)
HC
(25♂/38 ♀)
Wilcoxon
Median 95% CI Median 95% CI z-value p-value
Age in years 25.0 10.4/39.6 26.0 11.2/40.8 –.14 .89
Years of education 15.5 10.8/20.2 15.5 11.7/19.3 –.54 .588
MWT-B 30 (107*) 20.5/39.5 30 (107*) 25.1/34.9 –.76 .45
SCL-90-R (GSI) .16 –.18/.5 .12 –.2/.5 –1.32 .19
SCL-90-R (depression) .15 –.5/0.8 .08 –.4/0.6 –1.28 .202
Composite score: experience of negative affect –.19 –1.9/1.5 –.18 –1.9/1.6 –.04 .965
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uni-jena.de/vbm8) for the Statistical Parametric Mapping 8 Software
(SPM8, Welcome Trust Centre for Neuroimaging, UCL, London, UK;
http://www.ﬁl.ion.ucl.ac.uk/spm).
Before segmentation into tissue classes, images were visually
inspected to remove images with artefacts, manually aligned to the ori-
entation as deﬁned by the used brain templates, and the origin was set
on the anterior commissure. Afterwards, individual anatomical images
were classiﬁed into gray matter, white matter and cerebro-spinal ﬂuid
as well as three extra-cerebral tissue classes and transformed to the
stereotactical standard space as provided by the International Consor-
tium for Brain Mapping (6 tissue class template; http://www.loni.usc.
edu/ICBM) using the diffeomorphic image registration algorithm
(DARTEL) developed by Ashburner (2007). To account for the local nor-
malization degree, gray matter images were modulated with the non-
linear transformation parameters as computed during the
normalization procedures. The resulting images contain the volume
proportion of probabilistically assigned gray matter tissue for each
voxel. These graymatter tissue probability images were again inspected
visually and ﬁnally smoothed using an isotropic Gaussian kernel with a
full-width at a half-maximum of 8 mm. Note that each image of the re-
gional GMvolumewas corrected for individual brain size, since this step
is part of the VBM8 toolbox routine.
A voxel-wise whole-brain 2 × 3 analysis of covariance (ANCOVA)
with the factor of interest Group (H1stR vs. HC) was performed. The ad-
ditional factor scanner site allowed for detailed quality control regard-
ing possible inﬂuences of the multicenter setting: no interaction
between the two factorswas observed (p b .05 FWE corr.). Due to its im-
pact on brain volume, sex and theMWT-B were also used as covariates.
Finally, age was included as covariate of no interest. Only ﬁndings that
passed a signiﬁcance level of p b .05 (voxel level inference), whole-
brain family wise error (FWE) corrected for multiple comparison and
a cluster size of at least 10 adjacent voxels, are reported. Graymatter re-
gions that showed a signiﬁcant group effect were anatomically labeled
using the probabilistic cytoarchitectonic Anatomy toolbox (Eickhoff
et al., 2005) as implemented in SPM8. Based on the maps provided
by Amunts et al. (2005) (amygdala and hippocampus), the
cytoarchitectonic probabilities for these regions were computed. To
test for the direction of differences in gray matter volume, we applied
post hoct-tests at the peak voxel positions for the individual graymatter
values.
Due to our strong hypotheses based on previous literature, we per-
formed an adjustment of alpha error probabilities for the volumes of
the following a-priorideﬁned anatomical regions as provided by theAu-
tomated Anatomical Labelling (AAL) (Tzourio-Mazoyer et al., 2002)
brain atlas: bilateral hippocampus (volume: right 7.6 cm3, left
7.5 cm3), amygdala (volume: right 1.9 cm3, left 1.7 cm3) and DLPFC (?
≙ middle frontal gyrus; Brodmann areas 8, 9, 46; volume: right37.9 cm3, left 38.6 cm3) (see Supplementary Fig. S1). Only results with
an adjusted alpha error probability less than .05 family-wise error
(FWE) corrected for multiple comparisons are reported.
In order to probe whether differences in gray matter volume be-
tween H1stR and HC relate to subclinical depressive symptoms and ex-
perience of negative affect, we conducted, for both groups, voxel-wise
correlation analyses (non-normally distributed: Spearman's rho,
corrected for age, sex and MWT-B) for the self-report measure SCL-
Depr as well as the NegAff and local gray matter volume in the ROIs.
3. Results
3.1. Sociodemographical, psychometrical and clinical sample
characteristics
For results of sociodemographical, psychometrical and clinical data,
see Table 1.
3.2. Voxel-wise local gray matter volume — whole-brain analysis
VBM results revealed a main effect of Group for the amygdala bilat-
eral with larger local gray matter volume for H1stR subjects in the bilat-
eral amygdala (left: x=−21, y=2, z=−14, 278 voxels; right: x= 26,
y= 0, z=−15, 318 voxels) compared with HC subjects (see Fig. 1and
Supplementary Table S2). In contrast, HC did not have any relative in-
creases in local gray matter volume.
3.3. Voxel-wise local gray matter volume — ROI based analyses
Alpha error adjustment for a-priori deﬁned ROIs revealed a larger
local gray matter volume for H1stR subjects in the bilateral hippocam-
pus, bilateral amygdala and left DLPFC (see Table 2).
3.4. Correlation analysis
Correlation analysis revealed a signiﬁcant positive correlation be-
tween NegAff score and local gray matter volume in the left
(Spearman's rho = .43, pb .001) and right DLPFC (Spearman's rho =
.458, pb .001) in the H1stR group (see Fig. 2). Furthermore, a trend-
wise positive correlation between the SCL-Depr score and local gray
matter volume in the right hippocampus (Spearman's rho = .23, p=
.074) and left amygdala (Spearman's rho= .206, p=.102) has been ob-
served. For HC subjects, no signiﬁcant correlation was found.
4. Discussion
The main ﬁndings of our study are larger local gray matter volumes
in the bilateral amygdala in healthy relatives ofMDDpatients compared
Fig. 1.Whole-brain FWE correctable results. Middle panel: Clusters with a signiﬁcantmain effect of group. Left and right panels: Box plots for local graymatter volumes of H1stR (n=63)
and HC (n= 63) at peak voxel coordinates. The dots indicate the individual gray matter volumes. Abbreviation: CI— conﬁdence interval; H1stR — healthy ﬁrst-degree relatives of MDD
patients; HC— healthy control subjects.
Table 2
Differences in local gray matter volume between H1stR (n= 63) and HC (n = 63) subjects (alpha error probabilities adjusted for a-priori regions of interest). Abbreviations: CP —
cytoarchitectonic probability, H — hemisphere; DLPFC— dorsolateral prefrontal cortex; SF — superﬁcial group; CA — cornu ammonis.
Brain structure (CP) H Cluster size Z (peak) T (peak) p (FWE) MNI coord. (mm)
x y z
Amygdala (SF) L 389 5.67 6.10 b.001 –21 2 –14
Amygdala (SF) R 379 5.42 5.80 b.001 26 0 –15
DLPFC L 97 3.89 4.03 0.026 –32 47 28
Hippocampus (CA) L 480 4.47 4.68 0.001 –26 –6 –17
Hippocampus (CA) R 367 4.96 5.25 b.001 27 –4 –17
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(whole-brain analysis FWE corrected for multiple comparisons) this
study proves brain volume differences in high-risk subjects. According
to the literature, the evidence for volumetric differences in limbic re-
gions is inconsistent in MDD patients (Bora et al., 2012). While one
study in pediatric MDD (Rosso et al., 2005) as well as a meta-analysis
of VBM results in ﬁrst-episode MDD patients (Bora et al., 2012) showed
relatively reduced local gray matter volume in the amygdala, larger
amygdala volume has also been shown in samples of medicated MDD
patients (Hamilton et al., 2008; Malykhin et al., 2012) as well as in
early stages of MDD (Frodl et al., 2003, 2002; Lange and Irle, 2004;
van Eijndhoven et al., 2009). In contrast, previous studies in high-risk
subjects consistently reported a larger volume in the amygdala
(Boccardi et al., 2010; Saleh et al., 2012), which is in line with our ﬁnd-
ings. Further, it is of high interest that recent studies also linked larger
amygdala volume with psychological characteristics of depression, in
terms of heightened negative affect (Holmes et al., 2012) and negative
memory bias (Gerritsen et al., 2012), even in non-depressed subjects.
These aspects are considered to be important vulnerability factors, e.g.
frequent experience of ‘negative emotionality’ such as anxiety, low
mood, and hostility is characteristic of the personality trait of neuroti-
cism which is a well-known risk factor for MDD (Kendler et al., 2004;Steunenberg et al., 2006). In line with these ﬁndings, it has been
shown that unaffected twins of MDD patients have an increased ten-
dency to display negative affect in response to minor stressors in daily
life (Wichers et al., 2007) and show higher stress sensitivity (Wichers
et al., 2009) and that unaffected relatives differ from the standard pop-
ulation in terms of neural correlates of inhibition of negative emotional
information (Lisiecka et al., 2012). Albeit the present study did not ﬁnd
any signiﬁcant relationship between amygdala volume and experience
of negative affect and only a trend-wise relation to subclinical depres-
sive symptoms, we found a signiﬁcant positive correlation of the expe-
rience of negative affect and bilateral DLPFC volume in the H1stR group,
which was not present in the HC subjects.
In non-human primates, larger DLPFC volume and thickness were
related to resilience to stress exposure, which in turn has been linked
to emotional competences in humans (Schneider et al, 2013). Consider-
ing the close functional relationship between the DLPFC and amygdala,
it is of interest that also on a functional level the DLPFC has been well-
documented to be involved in emotion regulation in terms of showing
increased activity during, e.g. reappraisal of negative events and sup-
pression of negative memories (Goldin et al., 2008). Thus, the amygda-
la–prefrontal cortex circuitry is central to the emotional processing of
biologically salient stimuli, memory formation and response regulation
Fig. 2. Correlation between SCL depression score and local gray matter volume in the left amygdala and right hippocampus as well as the negative affect composite score and bilateral
DLPFC volume in H1stR (n= 63). Scatter plots between individual SCL — depression or negative affect score and gray matter volume at peak coordinate are shown. Additionally the
post-hoc regression model (solid line) and its 95% conﬁdence interval (dotted lines) are displayed. Abbreviations: rs – Spearman's rho; DLPFC — dorsolateral prefrontal cortex; Amyg —
amygdala, Hippo — hippocampus.
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(Hamilton and Gotlib, 2008; Rosenblau et al., 2012). Further, fMRI stud-
ies showed that the functional relationship between the amygdala and
the DLPFC is decreased in depression (Anand et al., 2005; Dannlowski
et al., 2009; Siegle et al., 2007). Thus, the larger gray matter volume in
the amygdalae and the correlation between DLPFC gray matter volume
and the experience of negative affect might be provoked by more in-
tense affective processes in the amygdala as well as more demanding
top down regulation of these processes by the DLPFC. Taking the ﬁnd-
ings together, we conclude that the found structural brain differences
in the amygdala might reﬂect an increased vulnerability for the onset
of MDD in healthy ﬁrst-degree relatives. To further understand the
role of the amygdala in the etiology of depression, non-MR-related ﬁnd-
ings should also be taken into account, like post-mortem
neuromorphometric and histopathological investigations (Manji et al.,
2001).
Additionally, our region-of-interest analyses methodologically
followed previous studies in this ﬁeld and identiﬁed altered graymatter
volumes in relatives of MDD patients in regions also highlighted by pre-
vious work: earlier studies found group differences in the amygdala
(Boccardi et al., 2010; Saleh et al., 2012), the hippocampus (Amico
et al., 2011; Baaré et al., 2010; Carballedo et al., 2012; Chen et al.,
2010; de Geus et al., 2007; Rao et al., 2010) and the DLPFC (Amico
et al., 2011; Carballedo et al., 2012) by means of region of interest
VBM analyses and manual tracing methods respectively. However,
whereas a larger amygdala volume in our H1stR participants is in line
with previous studies (Boccardi et al., 2010; Saleh et al., 2012), we
also found larger volume in the hippocampus as well as the DLPFCwhich is in contrast to the previous literature. Given themethodological
differences in sample size and sample characteristics, like the deﬁnition
of high-risk, further studies have to specify the direction and the precise
role of DLPFC and hippocampal volume in MDD etiology. On the one
hand, reduced hippocampal volumes were determined in subjects
with different risk factors related to depression (Chen et al., 2010;
Dannlowski et al., 2012; Teicher et al., 2012). On the other hand,
pointing to state-dependent effects, reduced hippocampal volumes
can be abolished by antidepressant treatment (Arnone et al., 2013;
Nordanskog et al., 2010; Tendolkar et al., 2013).
Limitations of our study arise from the question of how structural al-
terations inﬂuence brain function in terms of modulating the probabili-
ty of MDD in high-risk populations. In this context, it is worthy to
mention that the detailed relationship between altered brain structure
and its function is not fully understood, i.e. changes in local gray matter
volume might be due to various processes. For example, heightened
graymatter volume as describedmight point to amore ineffective func-
tional state in the respective brain system. Evidence fromanimal studies
points to a variability in local gray matter volume in amygdalar nuclei
related to neuropathic pain and depressive symptoms (Gonçalves
et al., 2008). Further, volumetric changesmight also be related to neuro-
chemical alterations, as discussed for MDD — like GABAergic deﬁcits
(Luscher et al., 2011), which were also linked to chronic deﬁcits in neu-
rotrophic support inmicemodels (Duman et al., 2000). Further, we con-
ducted a cross-sectional analysis. Longitudinal analyses assessing brain
volume before and after illness onset are needed to underline the im-
portance of neurobiological markers of vulnerability for MDD. More-
over, we do not know whether the studied high-risk subjects are
67N. Romanczuk-Seiferth et al. / NeuroImage: Clinical 5 (2014) 62–68indeed carriers of genetic risk factors for MDD. H1stR share approxi-
mately 50% of common genetic variants related to the disorder with
their affected family members, in addition to a degree of shared early
environment. Of course we cannot determine which speciﬁc variants
the studied high-risk subjects carry, given the limited number of
genome-wide supported variants associated with MDD, as well as we
do not know the speciﬁc ratio within our group of H1stR subjects
which develop a major depressive episode in the future. Since MDD
does manifest over the whole lifespan, it is also not possible to reliably
estimate the probability of MDD manifestation in the studied sample.
However, the close degree of kinship of our H1stR subjects to the affect-
ed family members suggests a high level of genetic similarity with the
MDD relatives.
Besides these limitations, the strengths of this study include the fact
that it was conducted on a representative sample of 63 subjects per
group and is therefore less likely to be affected by biases associated with
convenience sampling or clinical populations, which is also an important
advantage of the used high-risk approach. We advanced evidence in this
ﬁeld by applying very conservative statistical thresholds and reporting
whole brain FWE-corrected results as well as followed former research
strategies by replicatingprevious studies. Thus, it is very likely that the ob-
served larger volume in the amygdalae in healthy H1stR subjects is a reli-
able and valid ﬁnding and may represent a vulnerability factor for
developing MDD. At this point, future research has to replicate whether
volumetric alterations depict an endophenotype for MDD.
Disclosure
The ﬁrst authors had full access to all of the data in the study and
take responsibility for the integrity of the data and the accuracy of the
data analysis.
Source of funding
Funding for this study was provided by the sponsor-id="http://
dx.doi.org/10.13039/501100002347">German Ministry for Education
and Research (BMBF) grant NGFNplus MooDS (01 GS 08148). The
funding sourcewas not involved in study design, the collection, analysis
and interpretation of the presented data as well as writing of the report
or in the decision to submit the article for publication. Further, the au-
thors of this article declare no ﬁnancial or other conﬂicts of interest.
Acknowledgment
We thank Josephine Klaembt, Claudia Schütz and Carolin
Wackerhagen for help with data acquisition and Phöbe Schmierer for
assistance in data analysis.
Appendix A. Supplementary Material
Supplementary material associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.nicl.2014.05.015.
References
Amico, F., Meisenzahl, E., Koutsouleris, N., Reiser, M., Möller, H.-J., Frodl, T., 2011. Structur-
al MRI correlates for vulnerability and resilience to major depressive disorder. Journal
of Psychiatry & Neuroscience: JPN 36, 15–22. http://dx.doi.org/10.1503/jpn.
09018620964952.
Amunts, K., Kedo, O., Kindler, M., Pieperhoff, P., Mohlberg, H., Shah, N.J., Habel, U.,
Schneider, F., Zilles, K., 2005. Cytoarchitectonic mapping of the human amygdala, hip-
pocampal region and entorhinal cortex: intersubject variability and probability maps.
Anatomy and Embryology 210, 343–352. http://dx.doi.org/10.1007/s00429-005-
0025-516208455.
Anand, A., Li, Y., Wang, Y., Wu, J., Gao, S., Bukhari, L., Mathews, V.P., Kalnin, A., Lowe, M.J.,
2005. Activity and connectivity of brainmood regulating circuit in depression: a func-
tional magnetic resonance study. Biological Psychiatry 57, 1079–1088. http://dx.doi.
org/10.1016/j.biopsych.2005.02.02115866546.Arnone, D., McIntosh, A.M., Ebmeier, K.P., Munafò, M.R., Anderson, I.M., 2012. Magnetic
resonance imaging studies in unipolar depression: systematic review and meta-
regression analyses. European Neuropsychopharmacology: the Journal of the
European College of Neuropsychopharmacology 22, 1–16. http://dx.doi.org/10.
1016/j.euroneuro.2011.05.00321723712.
Arnone, D., McKie, S., Elliott, R., Juhasz, G., Thomas, E.J., Downey, D., Williams, S., Deakin,
J.F.W., Anderson, I.M., 2013. State-dependent changes in hippocampal grey matter in
depression. Molecular Psychiatry 18, 1265–1272. http://dx.doi.org/10.1038/mp.2012.
15023128153.
Ashburner, J., 2007. A fast diffeomorphic image registration algorithm. Neuroimage 38,
95–113. http://dx.doi.org/10.1016/j.neuroimage.2007.07.00717761438.
Baaré, W.F.C., Vinberg, M., Knudsen, G.M., Paulson, O.B., Langkilde, A.R., Jernigan, T.L.,
Kessing, L.V., 2010. Hippocampal volume changes in healthy subjects at risk of unipo-
lar depression. Journal of Psychiatric Research 44, 655–662. http://dx.doi.org/10.
1016/j.jpsychires.2009.12.00920096419.
Boccardi, M., Almici, M., Bresciani, L., Caroli, A., Bonetti, M., Monchieri, S., Gennarelli, M.,
Frisoni, G.B., 2010. Clinical and medial temporal features in a family with mood dis-
orders. Neuroscience Letters 468, 93–97. http://dx.doi.org/10.1016/j.neulet.2009.10.
06719874870.
Bora, E., Fornito, A., Pantelis, C., Yücel, M., 2012. Gray matter abnormalities in major de-
pressive disorder: a meta-analysis of voxel basedmorphometry studies. Journal of Af-
fective Disorders 138, 9–18. http://dx.doi.org/10.1016/j.jad.2011.03.04921511342.
Burke, H.M., Davis, M.C., Otte, C., Mohr, D.C., 2005. Depression and cortisol responses to
psychological stress: a meta-analysis. Psychoneuroendocrinology 30, 846–856.
http://dx.doi.org/10.1016/j.psyneuen.2005.02.01015961250.
Carballedo, A., Lisiecka, D., Fagan, A., Saleh, K., Ferguson, Y., Connolly, G., Meaney, J., Frodl,
T., 2012. Early life adversity is associated with brain changes in subjects at family risk
for depression. World Journal of Biological Psychiatry: the Ofﬁcial Journal of the
World Federation of Societies of Biological Psychiatry 13, 569–578. http://dx.doi.
org/10.3109/15622975.2012.66107922515408.
Chen, M.C., Hamilton, J.P., Gotlib, I.H., 2010. Decreased hippocampal volume in healthy
girls at risk of depression. Archives of General Psychiatry 67, 270–276. http://dx.
doi.org/10.1016/j.ypsy.2010.09.01620194827.
Cloninger, C.R., 1994. The Temperament and Character Inventory (TCI): A Guide to Its De-
velopment and Use. Center for Psychobiology of Personality, Washington University,
St. Louis, MO.
Costa, P.T., McCrae, R.R., 1992. Revised NEO Personality Inventory (NEO-PI-R) and NEO
Five-Factor Inventory (NEO-FFI) Professional Manual. Psychological Assessment Re-
sources, Odessa, FL.
Dannlowski, U., Ohrmann, P., Konrad, C., Domschke, K., Bauer, J., Kugel, H., Hohoff, C.,
Schöning, S., Kersting, A., Baune, B.T., Mortensen, L.S., Arolt, V., Zwitserlood, P.,
Deckert, J., Heindel, W., Suslow, T., 2009. Reduced amygdala–prefrontal coupling in
major depression: association with MAOA genotype and illness severity. Internation-
al Journal of Neuropsychopharmacology/Ofﬁcial Scientiﬁc Journal of the Collegium
Internationale Neuropsychopharmacologicum (CINP) 12, 11–22. http://dx.doi.org/
10.1017/S146114570800897318544183.
Dannlowski, U., Stuhrmann, A., Beutelmann, V., Zwanzger, P., Lenzen, T., Grotegerd, D.,
Domschke, K., Hohoff, C., Ohrmann, P., Bauer, J., Lindner, C., Postert, C., Konrad, C.,
Arolt, V., Heindel, W., Suslow, T., Kugel, H., 2012. Limbic scars: long-term conse-
quences of childhood maltreatment revealed by functional and structural magnetic
resonance imaging. Biological Psychiatry 71, 286–293. http://dx.doi.org/10.1016/j.
biopsych.2011.10.02122112927.
De, Geus E.J.C., Van’t, Ent D., Wolfensberger, S.P.A., Heutink, P., Hoogendijk, W.J.G.,
Boomsma, D.I., Veltman, D.J., 2007. Intrapair differences in hippocampal volume in
monozygotic twins discordant for the risk for anxiety and depression. Biological Psy-
chiatry 61, 1062–1071. http://dx.doi.org/10.1016/j.biopsych.2006.07.02617137562.
Derogatis, L.R., SCL-90-R: Administration, Scoring and Procedures Manual— II for the Re-
vised Version (SCL-90-R; German Version: G.H. Franke, 2002), second edition (1983).
Clinical Psychometric Research, Towson, MD.
Drevets, W.C., Price, J.L., Furey, M.L., 2008. Brain structural and functional abnormalities in
mood disorders: implications for neurocircuitry models of depression. Brain Struc-
ture & Function 213, 93–118. http://dx.doi.org/10.1007/s00429-008-0189-
x18704495.
Duman, R.S., Malberg, J., Nakagawa, S., D’Sa, C., 2000. Neuronal plasticity and survival in
mood disorders. Biological Psychiatry 48, 732–739. http://dx.doi.org/10.1016/
S0006-3223(00)00935-511063970.
Eickhoff, S.B., Stephan, K.E., Mohlberg, H., Grefkes, C., Fink, G.R., Amunts, K., Zilles, K., 2005.
A new SPM toolbox for combining probabilistic cytoarchitectonic maps and function-
al imaging data. NeuroImage 25, 1325–1335. http://dx.doi.org/10.1016/j.neuroimage.
2004.12.03415850749.
Esslinger, C., Walter, H., Kirsch, P., Erk, S., Schnell, K., Arnold, C., Haddad, L., Mier, D., Opitz,
von Boberfeld C., Raab, K., Witt, S.H., Rietschel, M., Cichon, S., Meyer-Lindenberg, A.,
2009. Neural mechanisms of a genome-wide supported psychosis variant. Science
(New York, N.Y.) 324, 60519407193.
First, M.B., Spitzer, R.L., Gibbon, M., Williams, J.B.W., Structured Clinical Interview for
DSM-IV-TR axis I disorders, research version, patient edition. (SCID-I/P; German ver-
sion: H.-U. Wittchen, M. Zaudig & T. Fydrich, 1997). Biometrics Research (2002). New
York State Psychiatric Institute, New York.
Friedman, L., Glover, G.H., 2006. Report on a multicenter fMRI quality assurance protocol.
Journal of Magnetic Resonance Imaging: JMRI 23, 827–839. http://dx.doi.org/10.
1002/jmri.2058316649196.
Frodl, T., Meisenzahl, E., Zetzsche, T., Bottlender, R., Born, C., Groll, C., Jäger, M., Leinsinger,
G., Hahn, K., Möller, H.-J., 2002. Enlargement of the amygdala in patients with a ﬁrst
episode of major depression. Biological Psychiatry 51, 708–714. http://dx.doi.org/10.
1016/S0006-3223(01)01359-211983184.
68 N. Romanczuk-Seiferth et al. / NeuroImage: Clinical 5 (2014) 62–68Frodl, T., Meisenzahl, E.M., Zetzsche, T., Born, C., Jäger, M., Groll, C., Bottlender, R.,
Leinsinger, G., Möller, H.-J., 2003. Larger amygdala volumes in ﬁrst depressive epi-
sode as compared to recurrent major depression and healthy control subjects. Biolog-
ical Psychiatry 53, 338–344. http://dx.doi.org/10.1016/S0006-3223(02)01474-
912586453.
Frodl, T., Möller, H.-J., Meisenzahl, E., 2008. Neuroimaging genetics: new perspectives in
research on major depression? Acta Psychiatrica Scandinavica 118, 363–372. http://
dx.doi.org/10.1111/j.1600-0447.2008.01225.x18644006.
Gerritsen, L., Rijpkema, M., van Oostrom, I., Buitelaar, J., Franke, B., Fernández, G.,
Tendolkar, I., 2012. Amygdala to hippocampal volume ratio is associated with nega-
tive memory bias in healthy subjects. Psychological Medicine 42, 335–343. http://
dx.doi.org/10.1017/S003329171100122X21740626.
Goldin, P.R.,McRae, K., Ramel,W., Gross, J.J., 2008. The neural bases of emotion regulation:
reappraisal and suppression of negative emotion. Biological Psychiatry 63, 577–586.
http://dx.doi.org/10.1016/j.biopsych.2007.05.03117888411.
Gonçalves, L., Silva, R., Pinto-Ribeiro, F., Pêgo, J.M., Bessa, J.M., Pertovaara, A., Sousa, N.,
Almeida, A., 2008. Neuropathic pain is associated with depressive behaviour and in-
duces neuroplasticity in the amygdala of the rat. Experimental Neurology 213, 48–56.
http://dx.doi.org/10.1016/j.expneurol.2008.04.04318599044.
Gottesman, I.I., Gould, T.D., 2003. The endophenotype concept in psychiatry: etymology
and strategic intentions. American Journal of Psychiatry 160, 636–645. http://dx.
doi.org/10.1176/appi.ajp.160.4.63612668349.
Hamilton, J.P., Gotlib, I.H., 2008. Neural substrates of increased memory sensitivity for
negative stimuli in major depression. Biological Psychiatry 63, 1155–1162. http://
dx.doi.org/10.1016/j.biopsych.2007.12.01518281017.
Hamilton, J.P., Siemer, M., Gotlib, I.H., 2008. Amygdala volume in major depressive disor-
der: a meta-analysis of magnetic resonance imaging studies. Molecular Psychiatry 13,
993–1000. http://dx.doi.org/10.1038/mp.2008.5718504424.
Hollon, S.D., Shelton, R.C., Wisniewski, S., Warden, D., Biggs, M.M., Friedman, E.S., Husain,
M., Kupfer, D.J., Nierenberg, A.a., Petersen, T.J., Shores-Wilson, K., Rush, A.J., 2006. Pre-
senting characteristics of depressed outpatients as a function of recurrence: prelimi-
nary ﬁndings from the STAR*D clinical trial. Journal of Psychiatric Research 40, 59–69.
http://dx.doi.org/10.1016/j.jpsychires.2005.07.00816243357.
Holmes, A.J., Lee, P.H., Hollinshead, M.O., Bakst, L., Roffman, J.L., Smoller, J.W., Buckner, R.L.,
2012. Individual differences in amygdala-medial prefrontal anatomy link negative
affect, impaired social functioning, and polygenic depression risk. Journal of Neurosci-
ence: the Ofﬁcial Journal of the Society for Neuroscience 32, 18087–18100. http://dx.
doi.org/10.1523/JNEUROSCI.2531-12.201223238724.
Kendler, K.S., Kuhn, J., Prescott, C.A., 2004. The interrelationship of neuroticism, sex, and
stressful life events in the prediction of episodes of major depression. American Jour-
nal of Psychiatry 161, 631–636. http://dx.doi.org/10.1176/appi.ajp.161.4.
63115056508.
Kim, M.J., Loucks, R.A., Palmer, A.L., Brown, A.C., Solomon, K.M., Marchante, A.N., Whalen,
P.J., 2011. The structural and functional connectivity of the amygdala: from normal
emotion to pathological anxiety. Behavioural Brain Research 223, 403–410. http://
dx.doi.org/10.1016/j.bbr.2011.04.02521536077.
Lange, C., Irle, E., 2004. Enlarged amygdala volume and reduced hippocampal volume in
young women with major depression. Psychological Medicine 34, 1059–1064.
http://dx.doi.org/10.1017/S003329170300180615554576.
Lehrl, S., 2005. Mehrfachwahl-Wortschatz-Intelligenztest MWT-Bﬁfth edition. Spitta
Verlag, Balingen.
Lisiecka, D.M., Carballedo, A., Fagan, A.J., Connolly, G., Meaney, J., Frodl, T., 2012. Altered
inhibition of negative emotions in subjects at family risk of major depressive disor-
der. Journal of Psychiatric Research 46, 181–188. http://dx.doi.org/10.1016/j.
jpsychires.2011.10.01022078646.
Luscher, B., Shen, Q., Sahir, N., 2011. The GABAergic deﬁcit hypothesis of major depressive
disorder. Molecular Psychiatry 16, 383–406. http://dx.doi.org/10.1038/mp.2010.
12021079608.
Malykhin, N.V., Carter, R., Hegadoren, K.M., Seres, P., Coupland, N.J., 2012. Fronto-limbic
volumetric changes in major depressive disorder. Journal of Affective Disorders
136, 1104–1113. http://dx.doi.org/10.1016/j.jad.2011.10.03822134041.
Manji, H.K., Drevets, W.C., Charney, D.S., 2001. The cellular neurobiology of depression.
Nature Medicine 7, 541–547. http://dx.doi.org/10.1038/8786511329053.
Nordanskog, P., Dahlstrand, U., Larsson, M.R., Larsson, E.-M., Knutsson, L., Johanson, A.,
2010. Increase in hippocampal volume after electroconvulsive therapy in patientswith depression: a volumetric magnetic resonance imaging study. Journal of ECT
26, 62–67. http://dx.doi.org/10.1097/YCT.0b013e3181a95da820190603.
Oldﬁeld, R.C., 1971. The assessment and analysis of handedness: the Edinburgh inventory.
Neuropsychologia 9, 97–113. http://dx.doi.org/10.1016/0028-3932(71)90067-
45146491.
Palazidou, E., 2012. The neurobiology of depression. British Medical Bulletin 101,
127–145. http://dx.doi.org/10.1093/bmb/lds00422334281.
Price, J.L., Drevets, W.C., 2012. Neural circuits underlying the pathophysiology of mood
disorders. Trends in Cognitive Sciences 16, 61–71. http://dx.doi.org/10.1016/j.tics.
2011.12.01122197477.
Rao, U., Chen, L.-A., Bidesi, A.S., Shad, M.U., Thomas, M.A., Hammen, C.L., 2010. Hippocam-
pal changes associated with early-life adversity and vulnerability to depression. Bio-
logical Psychiatry 67, 357–364. http://dx.doi.org/10.1016/j.biopsych.2009.10.
01720015483.
Rosenblau, G., Sterzer, P., Stoy, M., Park, S., Friedel, E., Heinz, A., Pilhatsch, M., Bauer, M.,
Ströhle, A., 2012. Functional neuroanatomy of emotion processing in major depres-
sive disorder is altered after successful antidepressant therapy. Journal of Psycho-
pharmacology (Oxford, England) 26, 1424–1433. http://dx.doi.org/10.1177/
026988111245077922767373.
Rosso, I.M., Cintron, C.M., Steingard, R.J., Renshaw, P.F., Young, A.D., Yurgelun-Todd, D.A.,
2005. Amygdala and hippocampus volumes in pediatric major depression. Biological
Psychiatry 57, 21–26. http://dx.doi.org/10.1016/j.biopsych.2004.10.02715607296.
Saleh, K., Carballedo, A., Lisiecka, D., Fagan, A.J., Connolly, G., Boyle, G., Frodl, T., 2012. Im-
pact of family history and depression on amygdala volume. Psychiatry Research 203,
24–30. http://dx.doi.org/10.1016/j.pscychresns.2011.10.00422867951.
Schneider, T.R., Lyons, J.B., Khazon, S., 2013. Emotional intelligence and resilience. Person-
ality and Individual Differences 55, 909–914. http://dx.doi.org/10.1016/j.paid.2013.
07.460.
Siegle, G.J., Thompson,W., Carter, C.S., Steinhauer, S.R., Thase, M.E., 2007. Increased amyg-
dala and decreased dorsolateral prefrontal BOLD responses in unipolar depression:
related and independent features. Biological Psychiatry 61, 198–209. http://dx.doi.
org/10.1016/j.biopsych.2006.05.04817027931.
Spielberger, C.D., 1989. State–Trait Anxiety Inventory: Bibliographysecond edition. Con-
sulting Psychologists Press, Palo Alto, CA.
Steunenberg, B., Beekman, A.T.F., Deeg, D.J.H., Kerkhof, A.J.F.M., 2006. Personality and the
onset of depression in late life. Journal of Affective Disorders 92, 243–251. http://dx.
doi.org/10.1016/j.jad.2006.02.00316545466.
Teicher, M.H., Anderson, C.M., Polcari, A., 2012. Childhood maltreatment is associated
with reduced volume in the hippocampal subﬁelds CA3, dentate gyrus, and
subiculum. Proceedings of the National Academy of Sciences of the United States of
America 109, E563–E572. http://dx.doi.org/10.1073/pnas.111539610922331913.
Tendolkar, I., van Beek, M., van Oostrom, I., Mulder, M., Janzing, J., Voshaar, R.O., van
Eijndhoven, P., 2013. Electroconvulsive therapy increases hippocampal and amygdala
volume in therapy refractory depression: a longitudinal pilot study. Psychiatry Re-
search 214, 197–203. http://dx.doi.org/10.1016/j.pscychresns.2013.09.00424090511.
Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N.,
Mazoyer, B., Joliot, M., 2002. Automated anatomical labeling of activations in SPM
using a macroscopic anatomical parcellation of the MNI MRI single-subject brain.
NeuroImage 15, 273–289. http://dx.doi.org/10.1006/nimg.2001.097811771995.
Van Eijndhoven, P., van Wingen, G., van Oijen, K., Rijpkema, M., Goraj, B., Jan, Verkes R.,
Oude, Voshaar R., Fernández, G., Buitelaar, J., Tendolkar, I., 2009. Amygdala volume
marks the acute state in the early course of depression. Biological Psychiatry 65,
812–818. http://dx.doi.org/10.1016/j.biopsych.2008.10.02719028381.
Wichers, M., Geschwind, N., Jacobs, N., Kenis, G., Peeters, F., Derom, C., Thiery, E.,
Delespaul, P., van Os, J., 2009. Transition from stress sensitivity to a depressive
state: longitudinal twin study. British Journal of Psychiatry: the Journal of Mental Sci-
ence 195, 498–503. http://dx.doi.org/10.1192/bjp.bp.108.05685319949197.
Wichers, M., Myin-Germeys, I., Jacobs, N., Peeters, F., Kenis, G., Derom, C., Vlietinck, R.,
Delespaul, P., Van Os, J., 2007. Genetic risk of depression and stress-induced negative
affect in daily life. British Journal of Psychiatry: the Journal of Mental Science 191,
218–223. http://dx.doi.org/10.1192/bjp.bp.106.03220117766761.
World Health Organization. Global health risks: Mortality and burden of disease attribut-
able to selected major risks. [WWW Document]2009
